Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.

about

Toxicodynamics of Mycotoxins in the Framework of Food Risk Assessment-An In Silico Perspective.

P2860

Q48184670-8C832F1B-EE4C-4A80-AB0C-5203E68F9B1B

P2860

Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.

Item

http://www.wikidata.org/entity/Q38663357

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Uncertainty and variability in ...... iprofloxacin and methotrexate.

@en

type

Item

label

Uncertainty and variability in ...... iprofloxacin and methotrexate.

@en

prefLabel

Uncertainty and variability in ...... iprofloxacin and methotrexate.

@en

P1476

Uncertainty and variability in ...... ciprofloxacin and methotrexate

@en

P2093

Ad M J Ragas

http://www.w3.org/2001/XMLSchema#string

Rik Oldenkamp

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment

The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin

Is the assumption of normality or log-normality for continuous response data critical for benchmark dose estimation?

Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.

Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.

Pharmacokinetics of ciprofloxacin in cystic fibrosis.

Assessment factors for human health risk assessment: a discussion paper.

Risk management. Science and the precautionary principle.

Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose

Critical effect sizes in toxicological risk assessment: a comprehensive and critical evaluation.

P304

261-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10408444.2015.1112768

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark Huijbregts

P577

2015-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286378807

http://www.w3.org/2001/XMLSchema#string

P698

26648512

http://www.w3.org/2001/XMLSchema#string

Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.

about

P2860

P2860

Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698